IFBLS

Updated:Tue, 02 May 2017

IBMS launch new look British Journal of Biomedical Science

bjbsfrontcover2

pdf Reasons to publish in the British Journal of Biomedical Science

The IBMS are delighted to announce the relaunch of the British Journal of Biomedical Science (BJBS) to be published by Taylor& Francis Group under the new Editorship of Dr Andrew Blann PhD FIBMS FRCPath FRCPE.

The British Journal of Biomedical Science (BJBS) is the profession’s leading journal, featuring authoritative papers and short reports on new laboratory techniques and principles.

The move to leading academic and professional publisher Taylor & Francis Group marks the beginning of a partnership with one of the leading publishers of online journals. In addition to a refreshed design, the latest edition of the BJBS will benefit from a new online platform offering new state-of-the-art features and functionality. 

New Editor Dr Blann, aims to make the BJBS increasingly relevant to its global laboratory scientist readership: “The BJBS will focus on research by laboratory scientists for laboratory scientists, ranging from research into the fundamental basis of the pathophysiology of human disease to improving patient outcomes. In addition to covering all the traditional and emergent disciplines in biomedical science, the BJBS will also publish research that encompasses the latest developments in industry.”.

In addition to a stronger focus on partnership with Industry, with technical reviews covering advances in methodology and instrumentation, the BJBS will also forge close ties with academic institutions, working closely with higher education institutions offering undergraduate and post graduate degree courses in Biomedical Sciences and featuring the best of undergraduate and postgraduate research in the field of biomedical science.   

From Spring 2017 the BJBS will feature an annual update summarising major advances in each of the biomedical science disciplines, supporting laboratory scientists in meeting professional and registration requirements to keep up to date with the latest developments in their field.

   

Contributors will also benefit from a streamlined online article submission process, with Editor, Dr Blann, keen to encourage high-quality original research submissions from the UK and overseas: “The BJBS is truly international Journal.  In 2015 over than half of the Journal’s published articles were from contributors based outside the UK. With the BJBS we aim to provide a platform for the dissemination of new and innovative information on the diagnosis and management of disease that is valuable to the practicing laboratory scientist anywhere in the world.”.

Further information and a selection of free access articles from current and previous editions of the British Journal of Biomedical Science are available at: http://explore.tandfonline.com/page/med/institute-of-biomedical-science-ibms-tbbs  

 

Editor’s notes:

The British Journal of Biomedical Science (BJBS) is committed to publishing high quality original research that represents a clear advance in the practice of biomedical science, and reviews that summarise recent advances in the field of biomedical science. The overall aim of the Journal is to provide a platform for the dissemination of new and innovative information on the diagnosis and management of disease that is valuable to the practicing laboratory scientist. http://www.tandfonline.com/tbbs

The Institute of Biomedical Science (IBMS) is the professional body for biomedical scientists in the United Kingdom.  With over 20,000 members it aims to promote and develop the role of biomedical science within healthcare to deliver the best possible service for patient care and safety. www.ibms.org

Taylor & Francis Group publishes more than 2,200 journals and over 4,000 new bookseach year, with a books backlist in excess of 60,000 specialist titles. We are providers of quality information and knowledge that enable our customers to perform their jobs efficiently, enhance their education, and help contribute to the advancement of their chosen market sectors.

Editor’s contact:

Sarah Holman, Communications and Press 020 7713 0214 ext 123, This email address is being protected from spambots. You need JavaScript enabled to view it.